Fact CheckerSign in

NCT07772804Not yet recruiting

Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation

Incidence of Postoperative Pulmonary Complications Between Mechanical Power-based Versus Conventional Lung Protective Ventilation During One-lung Ventilation: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 27 Aug 2026

Brief summary (registry, in English)

The goal of this clinical trial is to determine whether a mechanical power-based lung-protective ventilation strategy during one-lung ventilation reduces the incidence of postoperative pulmonary complications in adult patients undergoing lung resection surgery. Mechanical power during pressure-regulated volume control mode is calculated using the formula below. Mechanical power (J/min) = 0.098 x respiratory rate x tidal volume x (inspiratory airway pressure above positive end-expiratory pressure + positive end-expiratory pressure) The main questions it aims to answer are: * Does a mechanical power-based lung-protective ventilation strategy significantly lower the incidence of major postoperative pulmonary complications compared to conventional ventilation? * How does this strategy impact intraoperative hemodynamic and vital profiles (e.g., blood pressure, cardiac output, vasopressor requirements, and blood oxygen saturation) during one-lung ventilation? Participants will: * Be randomized to receive either a mechanical power-based lung-protective ventilation strategy or a conventional lung-protective ventilation strategy exclusively during one-lung ventilation. * Be closely monitored for the occurrence of major postoperative pulmonary complications (atelectasis, pneumonia, acute respiratory distress syndrome, and pulmonary aspiration) and adverse events for 1 month postoperatively.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
164 (estimated)
First submitted
14 Aug 2026
Start date
30 Aug 2026
Primary completion date
30 Aug 2027
Lead sponsor
Samsung Medical Center
Diseases
Lung cancer
NCT number
NCT07772804

What you commit to

  • Study type: Interventional
  • Planned participants: 164
  • From 30 Aug 2026 to the primary completion date, 30 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of thoracic surgery
  • Emergency surgery

Other

  • Pregnancy or lactation
  • Known contraindication to one-lung ventilation
  • Inability to provide informed consent or cooperate with the study protocol

Who the study is looking for

  • American Society of Anesthesiologists (ASA) physical status I-III
  • Elective thoracic surgery requiring lung lobectomy under one-lung ventilation
  • Age 18 years or older
  • Written informed consent obtained from the patient

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.